(14 days)
No
The summary describes ultrasound transducers and their technical specifications. There is no mention of AI or ML technology in the intended use, device description, or any other section.
No
The device is described as being "intended for diagnostic ultrasound imaging or fluid flow analysis," indicating its purpose is for diagnosis rather than treatment.
Yes
The "Intended Use / Indications for Use" section explicitly states that the transducers are "intended for diagnostic ultrasound imaging or fluid flow analysis of the human body."
No
The device description clearly outlines physical hardware specifications for transducers, including materials, dimensions, and frequencies, indicating it is a hardware device, not software-only.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is clearly stated as "diagnostic ultrasound imaging or fluid flow analysis of the human body." This describes an in-vivo (within the living body) diagnostic procedure, not an in-vitro (outside the living body) diagnostic test.
- Device Description: The device is described as "ATP Transducers" with specifications related to ultrasound technology (frequency, elements, bandwidth, etc.). These are components used in ultrasound systems for generating and receiving sound waves within the body.
- Input Imaging Modality: The input modality is "Diagnostic ultrasound," which is an in-vivo imaging technique.
IVD devices are typically used to examine specimens (like blood, urine, or tissue) outside of the body to diagnose diseases or conditions. This device operates by interacting directly with the human body using ultrasound waves.
N/A
Intended Use / Indications for Use
The TETRAD Model TC-C52-, -C84V--L74-ATP Transducers are intended for diagnostic ultrasound imaging or fluid flow analysis of the human body; specific indications for use are tabulated in Section 4.3 of this submission.
Product codes
90 ITX
Device Description
Technical specifications for the Model TC-C52-, -C84V-, -C95-, -CLA76-, -L74-ATP Transducers are as follows:
| Specifications | Tetrad TC C52-ATP | Tetrad TC C84V-ATP | Tetrad TC C95-ATP | Tetrad TC CLA76-ATP | Tetrad TC L74-ATP |
|---|---|---|---|---|---|
| Center Frequency | 3.0 MHz nominal | 6.0 MHz nominal | 6.0 MHz nominal | 4.0 MHz nominal | 6.0 MHz nominal |
| Number of Elements | 128 | 128 | 128 | 128 | 128 |
| Radius of Curvature | 40 mm | 12 mm | 8 mm | 76 mm | NA |
| Bandwidth -6dB | 70% nominal | 60% nominal | 60% nominal | 50% nominal | >50% |
| Elevation width | 15 mm | 5.5 mm | 4 mm | 15 mm | 5.5 mm |
| Elevation Focus | 80 mm | 25 mm | 25 mm | 75 mm | 25 mm |
| Lens material | silicone | Silicone | silicone | silicone | silicone |
| Pitch | 0.3 mm | 0.2 mm | 0.15 mm | 0.6 mm | 0.2 mm |
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
- TC-C52-ATP: Ophthalmic, Fetal, Abdominal
- TC-C84V-ATP: Ophthalmic, Fetal, Trans-vaginal
- TC-C95-ATP: Fetal, Trans-rectal, Trans-vaginal
- TC-CLA76-ATP: Fetal, Abdominal
- TC-L74-ATP: Abdominal, Intra-operative (abdominal, thoracic and PV), Small Organ (Thyroid, Breast, Testes, etc.), Neonatal Cephalic, Musculo-skel. (Conventional), Musculo-skel. (Superficial), Cardiac Adult, Cardiac Pediatric, Peripheral vessel
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
ATL HDI 3000 and HDI 5000 Systems (including Transducers C5-2, C8-4V, C9-5, C3.5, R76, L7-4. The C5-2 and L7-4 were most recently cleared for use with the HDI 5000 under K002003.
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1570 Diagnostic ultrasonic transducer.
(a)
Identification. A diagnostic ultrasonic transducer is a device made of a piezoelectric material that converts electrical signals into acoustic signals and acoustic signals into electrical signals and intended for use in diagnostic ultrasonic medical devices. Accessories of this generic type of device may include transmission media for acoustically coupling the transducer to the body surface, such as acoustic gel, paste, or a flexible fluid container.(b)
Classification. Class II.
0
K0191182
JAN 0 3 2002
510(k) Summary for TETRAD Model TC-C52-, -C84V-, -C95-, -CLA76-, -L74-ATP Transducers
- SPONSOR 1.
TETRAD Corporation 357 Inverness Drive, Suite A. Englewood, CO 80112-5866
Charles F. Hottinger, Ph.D., RAC, Contact Person: Regulatory Affairs Consultant
Telephone: 408-741-1006
November 27, 2001 Date Prepared:
2. DEVICE NAME
Proprietary Name:
Common/ Usual Name:
TETRAD Model TC-C52-, -C84V--L74-ATP Transducers Ultrasound Transducers
Diagnostic Ultrasound Transducer Classification Name: (21 CFR 892.1570, 90-ITX)
3. PREDICATE DEVICES
ATL HDI 3000 and HDI 5000 Systems (including Transducers C5-2, C8-4V, C9-5, C3.5, R76, L7-4. The C5-2 and L7-4 were most recently cleared for use with the HDI 5000 under K002003.
INTENDED USE 4.
The TETRAD Model TC-C52-, -C84V-, -C95-, -CLA76-, -L74-ATP Transducers are intended for diagnostic ultrasound imaging or fluid flow analysis of the human body; specific indications for use are tabulated in Section 4.3 of this submission.
RA
5. DEVICE DESCRIPTION
Technical specifications for the Model TC-C52-, -C84V-, -C95-, -CLA76-, -L74-ATP Transducers are as follows:
SK50
1
| Specifications | Tetrad TC-
C52-ATP | Tetrad TC-
C84V-ATP | Tetrad TC-
C95-ATP | Tetrad TC-
CLA76-ATP | Tetrad TC-
L74-ATP |
|---------------------|-----------------------|------------------------|-----------------------|-------------------------|-----------------------|
| Center Frequency | 3.0 MHz
nominal | 6.0 MHz
nominal | 6.0 MHz
nominal | 4.0 MHz
nominal | 6.0 MHz
nominal |
| Number of Elements | 128 | 128 | 128 | 128 | 128 |
| Radius of Curvature | 40 mm | 12 mm | 8 mm | 76 mm | NA |
| Bandwidth -6dB | 70% nominal | 60% nominal | 60% nominal | 50% nominal | >50% |
| Elevation width | 15 mm | 5.5 mm | 4 mm | 15 mm | 5.5 mm |
| Elevation Focus | 80 mm | 25 mm | 25 mm | 75 mm | 25 mm |
| Lens material | silicone | Silicone | silicone | silicone | silicone |
| Pitch | 0.3 mm | 0.2 mm | 0.15 mm | 0.6 mm | 0.2 mm |
BASIS FOR SUBSTANTIAL EQUIVALENCE 6.
The TETRAD Model TC-C52-, -C84V-, -C95-, -CLA76-, -L74-ATP Transducers are substantially equivalent to the corresponding ATL products which are currently in commercial distribution in the United States, since the subject devices are functionally similar and have the same intended uses as the corresponding predicate transducers. The only substantive differences being the following points that were determined during the clearance of the TC-C3-ATP (an equivalent to the Acuson C3 Transducer) under K002193.
The acoustic output levels of the TETRAD Transducers are equal to or slightly lower than those of their respective corresponding ATL Transducers.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular fashion around the symbol. The text is in all caps and is evenly spaced around the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 0 3 2002
TETRAD Corporation % Mr. Mark Job TÜV Product Services, Inc. 1775 Old Highway 8 NW Suite 104 NEW BRIGHTON MN 55112-1891 '
Re: K014182
Trade Name: TETRAD Transducer Models: TC-C52-ATP, TC-C84V-ATP, TC-C95-ATP,
TC-CLA76-ATP, TC-L74-ATP
Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasound transducer Regulatory Class: II Product Code: 90 ITX Dated: December 19, 2001 Received: December 20, 2001
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the ATL HDI 3000 and HDI 5000 Diagnostic Ultrasound Systems, as described in your premarket notification:
Transducer Model Number
TC-C52-ATP TC-C84V-ATP TC-C95-ATP TC-CLA76-ATP TC-L74-ATP
3
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. may pacinst is at that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801, please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
4
If you have any questions regarding the content of this letter, please contact Rodrigo C. Perez at (301) 594-1212.
Sincerely yours,
Nancyc brogdon
Nancy C. Brogdon
Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure(s)
5
ATL HDI 3000 and HDI 5000 Systems_____________________________________________________________________________________________________________________________________________ System: Transducer: TC-C52-ATP
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||
|---|---|---|---|---|---|---|---|---|
| General | ||||||||
| (Track I Only) | Specific | |||||||
| (Tracks I & III) | B | M | PWD | CWD | Color | |||
| Dopplera | Combined | |||||||
| Modesb | Other | |||||||
| Ophthalmic | Ophthalmic | |||||||
| Fetal | N1 | N1 | N1 | N1 | N1 | |||
| Abdominal | N1 | N1 | N1 | N1 | N1 | |||
| Intra-operative (Specify) | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Fetal Imaging | ||||||||
| & Other | Pediatric | |||||||
| Small Organ (Thyroid, | ||||||||
| Breast, Testes, etc.) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skel. | ||||||||
| (Conventional) | ||||||||
| Musculo-skel. (Superficial) | ||||||||
| Intra-luminal | ||||||||
| Other (Specify) | ||||||||
| Cardiac | Cardiac Adult | |||||||
| Cardiac Pediatric | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Other (Specify) | ||||||||
| Peripheral | ||||||||
| Vessel | Peripheral vessel | |||||||
| Other (Specify) |
N = new indication: predicate (ATL C5-2) cleared for this use with ATL HDI 3000 and ATL HDI 5000; a Includes Color M, Power (Ampl.) Doppler.
6B+M; B+PWD; B+Color Doppler, B+PWD+Color Doppler
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation
Prescription Use (Per 21 CFR 801.109)
| Nancy C. Brogdon | |
|---|---|
| (Division Sign-Off) | |
| Division of Reproductive, Abdominal, and Radiological Devices | |
| 510(k) Number | K014182 |
公
6
| System: | ATL HDI 3000 and HDI 5000 Systems |
|---|---|
| Transducer: | TC-C84V-ATP |
I ransuccr. I O Go v 7 N
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||
|---|---|---|---|---|---|---|---|---|
| General | Specific | B | M | PWD | CWD | Color | ||
| Dopplera | Combined | |||||||
| Modesb | Other | |||||||
| (Track I Only) | (Tracks I & III) | |||||||
| Ophthalmic | Ophthalmic | |||||||
| Fetal | N1 | N1 | N1 | N1 | N1 | |||
| Abdominal | ||||||||
| Intra-operative (Specify) | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Fetal Imaging | ||||||||
| & Other | Pediatric | |||||||
| Small Organ (Thyroid, | ||||||||
| Breast, Testes, etc.) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Trans-rectal | ||||||||
| Trans-vaginal | N1 | N1 | N1 | N1 | N1 | |||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skel. | ||||||||
| (Conventional) | ||||||||
| Musculo-skel. (Superficial) | ||||||||
| Intra-luminal | ||||||||
| Other (Specify) | ||||||||
| Cardiac Adult | ||||||||
| Cardiac | Cardiac Pediatric | |||||||
| Trans-esoph. (Cardiac) | ||||||||
| Other (Specify) | ||||||||
| Peripheral | ||||||||
| Vessel | Peripheral vessel | |||||||
| Other (Specify) |
N = new indication: predicate (ATL C8-4V) cleared for this use with ATL HDI 3000 and ATL HDI 5000; a Includes Color M, Power (Ampl.) Doppler
bB+M; B+PWD; B+Color Doppler, B+PWD+Color Doppler.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation
Prescription Use (Per 21 CFR 801.109)
Dancie brogdon
(Division Sign Division of Reproduct and Radiological Devic 510(k) Number
7
ATL HDI 3000 and HDI 5000 Systems_ System: Transducer:TC-C95-ATP Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||
|---|---|---|---|---|---|---|---|---|
| General | ||||||||
| (Track I Only) | Specific | |||||||
| (Tracks I & III) | B | M | PWD | CWD | Color | |||
| Dopplera | Combined | |||||||
| Modesb | Other | |||||||
| Ophthalmic | Ophthalmic | |||||||
| Fetal | N1 | N1 | N1 | N1 | N1 | |||
| Abdominal | ||||||||
| Intra-operative (Specify)d | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Fetal Imaging | ||||||||
| & Other | Pediatric | |||||||
| Small Organ (Thyroid, | ||||||||
| Breast, Testes, etc.) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Trans-rectal | N1 | N1 | N1 | N1 | N1 | |||
| Trans-vaginal | N1 | N1 | N1 | N1 | N1 | |||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skel. | ||||||||
| (Conventional) | ||||||||
| Musculo-skel. (Superficial) | ||||||||
| Intra-luminal | ||||||||
| Other (Specify) | ||||||||
| Cardiac | Cardiac Adult | |||||||
| Cardiac Pediatric | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Other (Specify) | ||||||||
| Peripheral | ||||||||
| Vessel | Peripheral vessel | |||||||
| Other (Specify) |
N'= new indication: predicate (ATL C9-5) cleared for this use with ATL HDI 3000 and ATL HDI 5000; a Includes Color M, Power (Ampl.) Doppler
6 + M; B+PWD; B+Color Doppler, B+PWD+Color Doppler.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation
Prescription Use (Per 21 CFR 801.109)
Nancy C. Brogdon
(Division Sigt Division of Reproduc and Radiological Devi 510(k) Numbe
8
| System: | ATL HDI 3000 | |||||||
|---|---|---|---|---|---|---|---|---|
| Transducer: | TC-CLA76-ATP | |||||||
| Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | ||||||||
| Clinical Application | Mode of Operation | |||||||
| General | ||||||||
| (Track I Only) | Specific | |||||||
| (Tracks I & III) | B | M | PWD | CWD | Color | |||
| Dopplera | Combined | |||||||
| Modesb | Other | |||||||
| Ophthalmic | Ophthalmic | |||||||
| Fetal Imaging | ||||||||
| & Other | Fetal | N1 | N1 | N1 | N1 | N1 | ||
| Abdominal | N1 | N1 | N1 | N1 | N1 | |||
| Intra-operative (Specify) | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | ||||||||
| Small Organ (Thyroid, | ||||||||
| Breast, Testes, etc.) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skel. | ||||||||
| (Conventional) | ||||||||
| Musculo-skel. (Superficial) | ||||||||
| Intra-luminal | ||||||||
| Other (Specify) | ||||||||
| Cardiac | Cardiac Adult | |||||||
| Cardiac Pediatric | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Other (Specify) | ||||||||
| Peripheral | ||||||||
| Vessel | Peripheral vessel | |||||||
| Other (Specify) |
N'= new indication: predicate (ATL C3.5R76) cleared for this use with ATL HDI 3000;
a Includes Color M, Power (Ampl.) Doppler
°B+M; B+PWD; B+Color Doppler, B+PWD+Color Doppler.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation
Prescription Use (Per 21 CFR 801.109)
Nancy hogdon
(Division Sign-Off)
Division of Reproduct ve. Abdon and Radiological Device 510(k) Number
9
ATL HDI 3000 and HDI 5000 Systems____ System:
Transducer:TC-L74-ATP Transucer. TO-L7+ATT
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | Other | ||||||
|---|---|---|---|---|---|---|---|---|
| General | ||||||||
| (Track I Only) | Specific | |||||||
| (Tracks I & III) | B | M | PWD | CWD | Color | |||
| Dopplera | Combined | |||||||
| Modesb | ||||||||
| Ophthalmic | Ophthalmic | |||||||
| Fetal Imaging | ||||||||
| & Other | Fetal | |||||||
| Abdominal | N1 | N1 | N1 | N1 | N1 | |||
| Intra-operativec (Specify) | N1 | N1 | N1 | N1 | N1 | |||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | ||||||||
| Small Organ (Thyroid, | ||||||||
| Breast, Testes, etc.) | N1 | N1 | N1 | N1 | N1 | |||
| Neonatal Cephalic | N1 | N1 | N1 | N1 | N1 | |||
| Adult Cephalic | ||||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skel. | ||||||||
| (Conventional) | N1 | N1 | N1 | N1 | N1 | |||
| Musculo-skel. (Superficial) | N1 | N1 | N1 | N1 | N1 | |||
| Intra-luminal | ||||||||
| Other (Specify) | ||||||||
| Cardiac | Cardiac Adultd | N1 | N1 | N1 | N1 | N1 | ||
| Cardiac Pediatricd | N1 | N1 | N1 | N1 | N1 | |||
| Trans-esoph. (Cardiac) | ||||||||
| Other (Specify) | ||||||||
| Peripheral | ||||||||
| Vessel | Peripheral vessel | N1 | N1 | N1 | N1 | N1 | ||
| Other (Specify) |
N = new indication: predicate (ATL L.7-4) cleared for this use with ATL HDI 3000 and ATL HDI 5000; a Includes Color M, Power (Ampl.) Doppler
6 +M; B+PWD; B+Color Doppler, B+PWD+Color Doppler.
°Intra-operative: abdominal, thoracic and PV.
Uncludes cardiac analysis
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation
Prescription Use (Per 21 CFR 801.109)
Nancy C. Brogdon
(Division Sig Division of Reproductive, Abdon and Radiological Devic 510(k) Number